The FDA has approved Zevaskyn (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare genetic skin disorder.

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...